282 related articles for article (PubMed ID: 24382590)
21. ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance.
Lee LH; Sadot E; Ivelja S; Vakiani E; Hechtman JF; Sevinsky CJ; Klimstra DS; Ginty F; Shia J
Hum Pathol; 2016 Jul; 53():97-104. PubMed ID: 26980037
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
23. Mutational and expressional analysis of SMC2 gene in gastric and colorectal cancers with microsatellite instability.
Je EM; Yoo NJ; Lee SH
APMIS; 2014 Jun; 122(6):499-504. PubMed ID: 24483990
[TBL] [Abstract][Full Text] [Related]
24. Epithelial-mesenchymal transition (EMT) protein expression in a cohort of stage II colorectal cancer patients with characterized tumor budding and mismatch repair protein status.
Kevans D; Wang LM; Sheahan K; Hyland J; O'Donoghue D; Mulcahy H; O'Sullivan J
Int J Surg Pathol; 2011 Dec; 19(6):751-60. PubMed ID: 21791486
[TBL] [Abstract][Full Text] [Related]
25. The putative tumor suppressor AIM2 is frequently affected by different genetic alterations in microsatellite unstable colon cancers.
Woerner SM; Kloor M; Schwitalle Y; Youmans H; Doeberitz Mv; Gebert J; Dihlmann S
Genes Chromosomes Cancer; 2007 Dec; 46(12):1080-9. PubMed ID: 17726700
[TBL] [Abstract][Full Text] [Related]
26. Frameshift mutation of a histone methylation-related gene SETD1B and its regional heterogeneity in gastric and colorectal cancers with high microsatellite instability.
Choi YJ; Oh HR; Choi MR; Gwak M; An CH; Chung YJ; Yoo NJ; Lee SH
Hum Pathol; 2014 Aug; 45(8):1674-81. PubMed ID: 24925220
[TBL] [Abstract][Full Text] [Related]
27. ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer.
Mehrvarz Sarshekeh A; Alshenaifi J; Roszik J; Manyam GC; Advani SM; Katkhuda R; Verma A; Lam M; Willis J; Shen JP; Morris J; Davis JS; Loree JM; Lee HM; Ajani JA; Maru DM; Overman MJ; Kopetz S
Clin Cancer Res; 2021 Mar; 27(6):1663-1670. PubMed ID: 33414133
[TBL] [Abstract][Full Text] [Related]
28. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
[TBL] [Abstract][Full Text] [Related]
29. A9 region in EPHB2 mutation is frequent in tumors with microsatellite instability. Analysis of prognosis.
Rafael S; Vidaurreta M; Veganzones S; De La Orden V; Mediero B; Gutierrez ML; Maestro ML
Anticancer Res; 2013 Nov; 33(11):5159-63. PubMed ID: 24222164
[TBL] [Abstract][Full Text] [Related]
30. ARID1A facilitates KRAS signaling-regulated enhancer activity in an AP1-dependent manner in colorectal cancer cells.
Sen M; Wang X; Hamdan FH; Rapp J; Eggert J; Kosinsky RL; Wegwitz F; Kutschat AP; Younesi FS; Gaedcke J; Grade M; Hessmann E; Papantonis A; Strӧbel P; Johnsen SA
Clin Epigenetics; 2019 Jun; 11(1):92. PubMed ID: 31217031
[TBL] [Abstract][Full Text] [Related]
31. Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.
Kelso TWR; Porter DK; Amaral ML; Shokhirev MN; Benner C; Hargreaves DC
Elife; 2017 Oct; 6():. PubMed ID: 28967863
[TBL] [Abstract][Full Text] [Related]
32. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
[TBL] [Abstract][Full Text] [Related]
33. ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.
Sato E; Nakayama K; Razia S; Nakamura K; Ishikawa M; Minamoto T; Ishibashi T; Yamashita H; Iida K; Kyo S
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29890703
[TBL] [Abstract][Full Text] [Related]
34. Exome Sequencing Landscape Analysis in Ovarian Clear Cell Carcinoma Shed Light on Key Chromosomal Regions and Mutation Gene Networks.
Murakami R; Matsumura N; Brown JB; Higasa K; Tsutsumi T; Kamada M; Abou-Taleb H; Hosoe Y; Kitamura S; Yamaguchi K; Abiko K; Hamanishi J; Baba T; Koshiyama M; Okuno Y; Yamada R; Matsuda F; Konishi I; Mandai M
Am J Pathol; 2017 Oct; 187(10):2246-2258. PubMed ID: 28888422
[TBL] [Abstract][Full Text] [Related]
35. Loss of ARID1A, ARID1B, and ARID2 Expression During Progression of Gastric Cancer.
Aso T; Uozaki H; Morita S; Kumagai A; Watanabe M
Anticancer Res; 2015 Dec; 35(12):6819-27. PubMed ID: 26637902
[TBL] [Abstract][Full Text] [Related]
36. Comprehensive evaluation of coding region point mutations in microsatellite-unstable colorectal cancer.
Kondelin J; Salokas K; Saarinen L; Ovaska K; Rauanheimo H; Plaketti RM; Hamberg J; Liu X; Yadav L; Gylfe AE; Cajuso T; Hänninen UA; Palin K; Ristolainen H; Katainen R; Kaasinen E; Tanskanen T; Aavikko M; Taipale M; Taipale J; Renkonen-Sinisalo L; Lepistö A; Koskensalo S; Böhm J; Mecklin JP; Ongen H; Dermitzakis ET; Kilpivaara O; Vahteristo P; Turunen M; Hautaniemi S; Tuupanen S; Karhu A; Välimäki N; Varjosalo M; Pitkänen E; Aaltonen LA
EMBO Mol Med; 2018 Sep; 10(9):. PubMed ID: 30108113
[TBL] [Abstract][Full Text] [Related]
37. Lack of APC somatic mutation is associated with early-onset colorectal cancer in African Americans.
Xicola RM; Manojlovic Z; Augustus GJ; Kupfer SS; Emmadi R; Alagiozian-Angelova V; Triche T; Salhia B; Carpten J; Llor X; Ellis NA
Carcinogenesis; 2018 Dec; 39(11):1331-1341. PubMed ID: 30239619
[TBL] [Abstract][Full Text] [Related]
38. Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis.
Timmermann B; Kerick M; Roehr C; Fischer A; Isau M; Boerno ST; Wunderlich A; Barmeyer C; Seemann P; Koenig J; Lappe M; Kuss AW; Garshasbi M; Bertram L; Trappe K; Werber M; Herrmann BG; Zatloukal K; Lehrach H; Schweiger MR
PLoS One; 2010 Dec; 5(12):e15661. PubMed ID: 21203531
[TBL] [Abstract][Full Text] [Related]
39. Associations Between Loss of ARID1A Expression and Clinicopathologic and Genetic Variables in T1 Early Colorectal Cancer.
Kishida Y; Oishi T; Sugino T; Shiomi A; Urakami K; Kusuhara M; Yamaguchi K; Kitagawa Y; Ono H
Am J Clin Pathol; 2019 Sep; 152(4):463-470. PubMed ID: 31263894
[TBL] [Abstract][Full Text] [Related]
40. RNF43 is frequently mutated in colorectal and endometrial cancers.
Giannakis M; Hodis E; Jasmine Mu X; Yamauchi M; Rosenbluh J; Cibulskis K; Saksena G; Lawrence MS; Qian ZR; Nishihara R; Van Allen EM; Hahn WC; Gabriel SB; Lander ES; Getz G; Ogino S; Fuchs CS; Garraway LA
Nat Genet; 2014 Dec; 46(12):1264-6. PubMed ID: 25344691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]